Baseline Demographics and Disease Characteristics from ORATORIO, a Phase III Trial Evaluating Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis

被引：0
|
作者：
Montalban, X. [1 ]
Hemmer, B. [2 ]
Rammohan, K. [3 ]
Giovannoni, G. [4 ]
de Seze, J. [5 ]
Bar-Or, A. [6 ]
Arnold, D. [6 ]
Sauter, A. [7 ]
Leppert, D. [8 ]
Chin, P. [9 ]
Garren, H. [8 ]
Messier, M. [8 ]
Wolinski, J. [10 ]
Kakarieka, A. [8 ]
Masterman, D. [9 ]
机构：
[1] Vall dHebron Univ Hosp, Dept Neurol Neuroimmunol, Barcelona, Spain
[2] Tech Univ Munich, Neurol, D-80290 Munich, Germany
[3] Univ Miami Hlth Syst, MS Ctr Excellence, Miami, FL USA
[4] Barts & London Queen Marys Sch Med & Dent, Neurosci, London, England
[5] Univ Hosp Strasbourg, Neurol, Strasbourg, France
[6] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada
[7] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[8] F Hoffmann La Roche & Co Ltd, Neurosci, CH-4002 Basel, Switzerland
[9] Genentech Roche, Neurosci, San Francisco, CA USA
[10] Univ Texas Houston, Sch Med, Neurosci, Houston, TX USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2015年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
F3049
引用
收藏
页码：706 / 706
页数：1
相关论文
共 50 条
  • [31] ASCEND study of natalizumab efficacy on reducing disability in patients with secondary progressive multiple sclerosis: baseline demographics and disease characteristics
    Mikol, D.
    Freedman, M. S.
    Goldman, M. D.
    Hartung, H-P
    Havrdova, E.
    Jeffery, D.
    Kapoor, R.
    Miller, A.
    Sellebjerg, F.
    Lee, S.
    Chen, Y.
    Cadavid, D.
    Ticho, B.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 507 - 508
  • [32] SOCIOECONOMIC VALUE OF OCRELIZUMAB IN THE TREATMENT OF PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
    Di Maio, D.
    Wu, J.
    Stavropoulos, A.
    Sanchez, Alvarez J.
    Diles, D.
    VALUE IN HEALTH, 2021, 24 : S161 - S161
  • [33] An exploratory analysis of the risk of being restricted to wheelchair in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Giovannoni, G.
    de Seze, J.
    Kappos, L.
    Montalban, X.
    Hauser, S. L.
    Belachew, S.
    Bernasconi, C.
    Buffels, R.
    Chin, P.
    Deol-Bhullar, G.
    Wolinsky, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 494 - 494
  • [34] Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO
    Gibiansky, Ekaterina
    Petry, Claire
    Mercier, Francois
    Gunther, Andreas
    Herman, Ann
    Kappos, Ludwig
    Hauser, Stephen
    Yamamoto, Yumi
    Wang, Qing
    Model, Fabian
    Kletzl, Heidemarie
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (06) : 2511 - 2520
  • [35] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 317 - 318
  • [36] Real world experience with ocrelizumab in patients with primary progressive multiple sclerosis
    Lopez Ruiz, R.
    Dotor Garcia-Soto, J.
    Hiraldo, J. D. G.
    Ruiz-Pena, J. L.
    Paramo Camino, M. D.
    Ruiz De Arcos, M.
    Navarro Mascarell, G.
    Eichau Madueno, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 301 - 302
  • [37] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Chognot, Cathy
    Jessop, Nikki
    Pradhan, Ashish
    Prajapati, Kalpesh
    Wolinsky, Jerry S.
    NEUROLOGY, 2021, 96 (15)
  • [38] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Guittari, C. J.
    Koendgen, H.
    Li, C.
    Marcillat, C.
    Wormser, D.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 324 - 325
  • [39] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Koendgen, Harold
    Li, Carrie
    Marcillat, Carole
    Pradhan, Ashish
    Wormser, David
    Wolinsky, Jerry
    NEUROLOGY, 2018, 90
  • [40] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Craveiro, Licinio
    Hughes, Richard
    Prajapati, Kalpesh
    Koendgen, Harold
    Pradhan, Ashish
    Wolinsky, Jerry S.
    NEUROLOGY, 2020, 94 (15)
12345